Pathological expansion of adipose tissue contributes to the metabolic syndrome. Distinct depots develop at various times under different physiological conditions. The transcriptional cascade mediating adipogenesis is established in vitro, and centres around a core program involving PPARγ and C/EBPα. We developed an inducible, adipocyte-specific knockout system to probe the requirement of key adipogenic transcription factors at various stages of adipogenesis in vivo. C/EBPα is essential for all white adipogenic conditions in the adult stage, such as adipose tissue regeneration, adipogenesis in muscle and unhealthy expansion of white adipose tissue during high-fat feeding or due to leptin deficiency. Surprisingly, terminal embryonic adipogenesis is fully C/EBPα independent, but does however depend on PPARγ; cold-induced beige adipogenesis is also C/EBPα independent. Moreover, C/EBPα is not vital for adipocyte survival in the adult stage. We reveal a surprising diversity of transcriptional signals required at different stages of adipogenesis in vivo.
White adipose tissue (WAT) has been recognized as a major endocrine organ that is highly dynamic and metabolically active [1] [2] [3] . Adipocytes from anatomically distinct adipose tissues have unique functions and contribute differentially to whole-body insulin resistance, dyslipidemia, chronic inflammation, and numerous other metabolic disorders [4] [5] [6] [7] . There are two phases of adipogenesis: commitment of multipotent stem cells to the pre-adipocyte lineage and terminal differentiation of pre-adipocytes to mature adipocytes 8 . Furthermore, mechanisms must be in place to maintain the function and terminally differentiated state of the adipocyte. The transcriptional cascade driving adipogenesis has been extensively studied in cellular models of adipogenesis, such as the murine 3T3-L1 cell line, primary stromalvascular derived cells or mouse embryonic fibroblasts [8] [9] [10] . Elegant work in 3T3-L1 cells has defined key transcription factors that are essential for the commitment of pre-adipocytes to undergo maturation in vitro 11, 12 . At the centre of this transcriptional network is the nuclear hormone receptor PPARγ, which serves as the 'master regulator' of adipogenesis, as well as C/EBPα, the founding member of the CCAAT/enhancer-binding family. Numerous additional transcriptional regulators have been implicated in adipogenesis; however, PPARγ and C/EBPα have been widely viewed as 'core' regulators of all forms of adipogenesis. Moreover, genome-wide analyses of promoter architecture has revealed that PPARγ and C/EBPα co-occupy and regulate a large portion of the global adipocyte transcriptome in vitro, suggesting that these two factors coordinate the maintenance of the adipocyte morphology and function 13, 14 .
Adipogenesis in vivo is governed by a more complex set of events than in a tissue culture setting [15] [16] [17] [18] ; when and where these specific factors drive the development and expansion of fat pads in vivo cannot be determined in the in vitro system 19 . To better understand the dynamics of adipogenesis in different locations and under different physiological conditions, we developed a doxycyclineinducible adipocyte-specific knockout system that is active during late adipocyte maturation and/or in mature adipocytes. This system enables us to explore the role of specific components of the adipogenic transcriptional machinery in different locations and under different conditions of late-stage adipogenesis in vivo, as well as their role in terminally differentiated adipocytes. In this study, we focused predominantly on the transcription factor C/EBPα as a tool to address the question of how the loss of C/EBPα function during adipocyte maturation affects adipocyte maturation and maintenance in different fat depots in response to developmental and nutritional conditions. Our results show that the transcriptional signals needed during adipocyte maturation are highly diverse within the same depot at different times of lifespan and under different conditions of adipogenesis. Supplementary Fig. 9 . intensity was measured by ImageJ software (right). n = 3 wells of a six-well plate for each group. This experiment is representative of three independent experiments. (c,d) Immunofluorescence stains for C/EBPα (red), DAPI (blue) and perilipin (green) (c) or C/EBPα (red), DAPI (blue) and BODIPY (green) (d) on differentiated adipocytes treated with doxycycline for 3 days. These images are representative of two independent experiments. Unprocessed original scans of blots are shown in Supplementary Fig. 9 .
A R T I C L E S

RESULTS
Adipocyte-specific inducible knockout of C/EBPα
To achieve an inducible knockout of C/EBPα in adipocytes, we crossed three mouse lines: an adiponectin promoter-driven 'tet-on' transcription factor rtTA (Adn-rtTA) line we recently generated 20,21 , a tet-responsive CRE (TRE-Cre) line 22 , and the conditional C/EBPα flox/flox line 23 . In the absence of doxycycline, C/EBPα is expressed normally in all cells (Adn-C/EBPα flox/flox ). On treatment with doxycycline, rtTA activates the TRE promoter to induce Cre expression. Cre protein will subsequently eliminate the floxed Supplementary Fig. 1a ), while C/EBPα expression in other tissues was not altered ( Supplementary Fig. 1b ). We then separated adipocytes from the stromal vascular fraction (SVF) and a significant drop of C/EBPα mRNA levels was observed in the floated adipocytes from sWAT and eWAT, while comparable C/EBPα expression levels were seen in the SVFs ( Supplementary Fig. 1c ), indicating that the C/EBPα knockout is adipocyte specific. The mRNA levels of C/EBPβ (refs 24,25) , in contrast, were not altered after C/EBPα elimination ( Supplementary Fig. 1c ), indicating that the decrease of C/EBPα in adipocytes has no impact on C/EBPβ expression. Protein levels of C/EBPα were also reduced markedly in the sWAT and eWAT after 4 days of doxycycline chow diet treatment, while C/EBPα in the liver was not altered ( Supplementary  Fig. 1d ). We next isolated and differentiated SVF from sWAT of Adn-C/EBPα flox/flox mice. C/EBPα expression was markedly upregulated on day 1 of differentiation and reached its peak by day 2; PPARγ expression was greatly upregulated on day 2 and reached its peak by day 3 (Supplementary Fig. 1e ). Adiponectin and rtTA mRNA levels are increased only by the third day of differentiation and reached their peak on day 4, when the cells are starting to exhibit a true adipocyte morphology, with visible lipid accumulation revealed by Oil red O staining ( Supplementary  Fig. 1f ). Thus, adiponectin and rtTA are activated only in the later stages of differentiation, during adipocyte maturation, after C/EBPα and PPARγ start to be induced. To determine whether C/EBPα deficiency alters the binding capacity of C/EBPβ and PPARγ on their target sequences, we performed chromatin immunoprecipitation (ChIP) assays with anti-C/EBPα, C/EBPβ or PPARγ antibodies in differentiated adipocytes obtained on in vitro differentiation of SVF cells from control or Adn-C/EBPα −/− sWAT ( Supplementary  Fig. 1g ). ChIP-qPCR analysis showed that the occupancy of C/EBPα was reduced markedly on the CD36 and C/EBPβ promoters. Binding of C/EBPβ or PPARγ on CD36 and C/EBPβ promoters was unaltered, indicating that the deletion of C/EBPα does not alter the binding capacity of C/EBPβ or PPARγ ( Supplementary Fig. 1g ). These results enable us to inducibly eliminate genes during the maturation of adipocytes, not only independent of the formation of adipocyte progenitors, but also independent of the early activation of C/EBPα and PPARγ.
Embryonic adipogenesis depends on PPARγ, but not C/EBPα C/EBPα is essential for adipogenesis in vitro 26, 27 , but the cellautonomous role of C/EBPα in adipogenesis in vivo has not yet been clearly demonstrated [28] [29] [30] . We first addressed whether C/EBPα is required during the initial wave of adipogenesis during the perinatal period. Our previous AdipoChaser system showed that the development of eWAT in males and parametrial WAT (pWAT) in females is postnatal 31 . In contrast, sWAT differentiation is initiated during embryonic days (E) 14-18, and the number of adipocytes in sWAT remains quite stable postnatally 31 . To knockout C/EBPα in late embryonic development of sWAT, control female mice were mated with male Adn-C/EBPα flox/flox mice. Pregnant female mice were put on doxycycline chow diet from E11 to postnatal day (P) 16 (Adn-C/EBPα −/− ; Fig. 1a ). As previously shown, Cre expression is completely lost after overnight doxycycline withdrawal 31 ; any adipocyte developed after P16 expresses C/EBPα, but adipocytes developed before P16 do not express C/EBPα. C/EBPα protein levels were almost completely depleted in the sWAT of Adn-C/EBPα −/−(E11−P16) mice, while normal expression is observed in eWAT and liver (Fig. 1b ). Immunofluorescence staining further confirmed that C/EBPα is expressed in the adipocyte nucleus in eWAT ( Supplementary Fig. 2a ), but not sWAT of Adn-C/EBPα −/−(E11−P16) mice ( Supplementary Fig. 2b ). Remarkably, both sWAT and eWAT/pWAT tissue mass and average adipocyte size in the adult Adn-C/EBPα −/−(E11−P16) mice were comparable to their control littermates (Fig. 1c,d and Supplementary Fig. 2c ). The average adipocyte numbers per image are: sWAT control group, 358; sWAT Adn-C/EBPα −/−(E11−P16) group, 445; eWAT control group, 362; eWAT Adn-C/EBPα −/−(E11−P16) group 324. n = 2 images per group. The total number of adipocytes in Adn-C/EBPα −/−(E11−P16) mice is 101% (sWAT) and 121% (eWAT) of their control littermates. C/EBPα-deficient sWATs also had normal adipocyte morphology by haematoxylin and eosin (H&E) staining ( Fig. 1e and Supplementary  Fig. 2d ). Essentially all adipocytes in sWAT, eWAT and pWAT from Adn-C/EBPα −/−(E11−P16) mice represent live adipocytes with positive perilipin staining ( Fig. 1f and Supplementary Fig. 2e ). BAT from these Adn-C/EBPα −/−(E11−P16) mice also had much reduced C/EBPα protein levels ( Supplementary Fig. 2f ), but slightly enlarged adipocyte cell size ( Supplementary Fig. 2g,h) . When mice were put on doxycycline chow diet from P0 to P42, during the critical period of eWAT development ( Supplementary Fig. 3a-d) , or from E11 to P42, during both sWAT and eWAT development ( Supplementary Fig. 3e-g) , Adn-C/EBPα −/− mice also had normal sWAT and eWAT tissue mass. This leads us to conclude that C/EBPα is not required for the maturation of sWAT during embryogenesis or eWAT during early postnatal development.
PPARγ is necessary and sufficient to induce adipocyte differentiation in vitro 9 . We also generated an adipocyte-specific inducible PPARγ knockout model (Adn-PPARγ flox/flox ) by crossing Adn-rtTA mice with TRE-Cre mice and PPARγ flox/flox mice 32 . The adult Adn-PPARγ −/−(E11−P16) male offspring (Fig. 1a ) had small amounts of sWAT (Fig. 1g ). These very small sWAT pads of Adn-PPARγ −/−(E11−P16) mice have disrupted adipocyte morphology (Fig. 1h) , with widespread negative perilipin staining (Fig. 1i ). The lack of sWAT enhanced eWAT generation, resulting in increased eWAT mass (by 36%) and increased adipocyte size (Fig. 1g) , with normal viability and morphology (Fig. 1h,i) . These observations indicate that, in contrast to C/EBPα, deleting PPARγ in the same critical late developmental stages of sWAT totally blocked the formation of sWAT, leading to a compensatory overgrowth of eWAT.
Adipocyte morphology is not maintained by C/EBPα
To determine whether adipocytes without C/EBPα are viable in vitro, we added doxycycline to fully differentiated adipocyte cultures derived from SVF of sWAT from Adn-C/EBPα flox/flox or control littermates. C/EBPα expression in Adn-C/EBPα −/− adipocytes was effectively eliminated after 3 days of doxycycline treatment (Fig. 2a ). These C/EBPα-deficient adipocyte cultures had a similar density of Oil red O staining compared with control cultures (Fig. 2b) , with positive perilipin (Fig. 2c ) and lipid staining (Fig. 2d ), on par with control adipocytes.
In vivo studies showed that on putting the Adn-C/EBPα flox/flox mice on a doxycycline chow diet (Fig. 3a) , insulin-stimulated phosphorylation of Akt and Erk1/2 was significantly impaired in the sWAT and eWAT (Fig. 3b ), but not in the liver (Fig. 3b ). These results indicate that C/EBPα in white adipocytes cell-autonomously regulates insulin signalling. Consistent with the in vitro observations (Fig. 2c,d) , adipocytes in these Adn-C/EBPα −/− mice have relatively normal morphology and adipocyte size distribution (Fig. 3c ), indicating that these WATs have a comparable number of adipocytes. The average adipocyte numbers per image are sWAT control group, 167; sWAT Adn-C/EBPα −/− group, 209; eWAT control group, 72; eWAT Adn-C/EBPα −/− group 67. n = 2 images per group. Notably, the plasma adiponectin is very sensitive to C/EBPα levels in mature adipocytes. Deletion of C/EBPα led to a rapid decrease of adiponectin in circulation that dropped to 14% of their control littermates after 8 days (Fig. 3d ). Interestingly, circulating adiponectin is reduced by 34% in the male Adn-C/EBPα −/−(E11−P16) mice (Fig. 3e ), suggesting that sWAT contributes about one-third of the adiponectin in systemic circulation. In Adn-PPARγ −/−(E11−P16) mice, circulating adiponectin is reduced only by 24% (Fig. 3f) , reflecting the fact that the increased eWAT tissue mass compensates by secreting more adiponectin into circulation (Fig. 1g) . Figure 8 The complexity of adipogenesis in vivo. A schematic summary of the complexity of adipogenesis in vivo: C/EBPα is not universally required for all adipogenic conditions. First of all, terminal adipocyte differentiation in sWAT during embryonic development is fully C/EBPα independent. In contrast, C/EBPα is essential for all of the terminal white adipogenesis conditions in the adult stage we had tested. These conditions are: adipose tissue expansion during HFD feeding or in leptin-deficient mice, regeneration of adipose tissue after ablation and muscle tissue adipogenesis after injury. However, in the adult stage, C/EBPα expression is also not required for cold-induced beige adipogenesis. Our data suggest that white adipocyte precursors in the adult animal respond to distinct signals, different from white adipocyte precursors in embryogenesis or beige adipocyte precursors.
C/EBPα transcriptional targets are distinct from PPARγ targets
Our data emphasize that C/EBPα deficiency in mature adipocytes has distinct phenotypic consequences compared with PPARγ deficiency [32] [33] [34] . We took a systematic, un-biased approach to determine the direct (acute) transcriptional programs that are specifically dependent on C/EBPα or PPARγ in mature white adipocytes, after doxycycline chow diet feeding for 3 days (Fig. 3g,h and Supplementary Fig. 4 ). Only 26 genes were significantly changed in C/EBPα-deficient fat cells, compared with 298 genes altered when PPARγ is deleted. Surprisingly, only 10 genes were in common between these two target groups ( Fig. 3h and Supplementary Fig. 4b) .
These data indicate that although C/EBPα and PPARγ cross-regulate each other and co-occupy a large common cistrome in the mature adipocyte 13, 14 , the distinct global programs directly dependent on each factor in vivo are quite distinct.
Adipocyte C/EBPα is essential for glucose/ lipid metabolism during HFD feeding
There is much that remains to be learned concerning the role of C/EBPα in maintaining the adipocyte phenotype. The phenotypes described previously are too complicated owing to profound effects of deleting C/EBPα in adipocyte progenitors and other cell types 28, 30, 35 . When adult mice were challenged with a doxycycline high fat diet (HFD; Fig. 4a ), Adn-C/EBPα −/− mice still gained body weight, but at a lower rate (Fig. 4b) . In vivo computed tomography scans and NMR body composition analysis revealed that Adn-C/EBPα −/− mice still have considerable amounts of WAT after 4 weeks of doxycycline HFD feeding (Fig. 4c,d ). The differences in body weights became significant only around 5 weeks after initiation of HFD feeding (Fig. 4b) , around the same time that we observed adipogenesis in WAT after hypertrophy 31 . Consistent with the findings in mice on chow doxycycline diet (Fig. 3c) , adipocytes in these Adn-C/EBPα −/− mice had relatively normal morphology and average adipocyte size in sWAT, eWAT and BAT (Fig. 4e) . The average adipocyte numbers per image are: sWAT HFD control group, 42; sWAT HFD Adn-C/EBPα −/− group, 42; eWAT HFD control group, 41; eWAT HFD Adn-C/EBPα −/− group 43. n = 2 images per group. The total number of adipocytes in HFD Adn-C/EBPα −/−(E11−P16) mice is 115% (sWAT) and 81% (eWAT) of their HFD control littermates. These adipocytes in Adn-C/EBPα −/− mice are viable with 100% of cells exhibiting a positive perilipin signal (Fig. 4f ). Intraperitoneal glucose tolerance tests (GTT) and insulin tolerance tests (ITT) showed that Adn-C/EBPα −/− mice have impaired glucose tolerance and are more insulin resistant after several weeks of doxycycline HFD feeding (Fig. 4g,h) .
The inducible adipocyte-specific C/EBPα deletion also altered whole-body lipid metabolism. Triglyceride content of the very lowdensity lipoprotein (VLDL) fractions of Adn-C/EBPα −/− mice was significantly higher, but cholesterol content of the high-density lipoprotein fractions was unaltered ( Supplementary Fig. 5a,b) . Meanwhile, Adn-C/EBPα −/− mice had an increased whole-body triglyceride clearance rate ( Supplementary Fig. 5c ). Moreover, the rate of hepatic VLDL-triglyceride production in Adn-C/EBPα −/− mice was almost doubled ( Supplementary Fig. 5d ). During β-3 adrenergic receptor agonist treatment, Adn-C/EBPα −/− mice showed slightly decreased levels of NEFA and triglyceride in circulation, while glucose levels were significantly increased ( Supplementary Fig. 5e-g) . Thus, the Adn-C/EBPα −/− mice had increased whole-body triglyceride clearance combined with increased hepatic VLDL-triglyceride production. However, hepatic triglyceride and cholesterol levels were not changed in these mice ( Supplementary Fig. 5h,i) . Metabolic cage studies showed that during week 7 of doxycycline HFD feeding, Adn-C/EBPα −/− mice had significantly higher physical activity ( Supplementary Fig. 5j ) and oxygen consumption (Supplementary Fig. 5k) , with no appreciable alteration in respiratory exchange ratio (RER) and food intake, compared with control littermates ( Supplementary Fig. 5l,m) .
Ceramide levels positively correlate with impaired glucose tolerance and insulin sensitivity 36 , and adiponectin is highly involved in controlling these lipids 37 . We observed a widespread upregulation in the concentration of sphingoid bases, ceramide and sphingomyelin content in sWAT and eWAT after 1 month of doxycycline HFD feeding ( Supplementary Fig. 6a-i) . The rapid drop of adiponectin levels in circulation after the induced C/EBPα elimination in WAT (Fig. 3d) , combined with our previous studies 37 , suggests that C/EBPα is at least partially regulating ceramide metabolism through controlling adiponectin expression. Long-term C/EBPα elimination also altered the expression levels of critical transcription factors, key adipokines and enzymes. One month of doxycycline HFD feeding decreased PPARγ and LXRα ( Supplementary Fig. 6j ), adiponectin, resistin and CD36 ( Supplementary Fig. 6k ), as well as SCD-1 and Elovl6 ( Supplementary Fig. 6l ).
To have a more complete profile of altered gene expression on C/EBPα deletion, we collected microarray data from sWAT of Adn-C/EBPα −/− mice after 3 days or 1 month of doxycycline HFD treatment ( Supplementary Fig. 4c ). This yielded a total of 110 (3 days) and 702 (1 month) genes whose expression was significantly altered ( Supplementary Fig. 4d,e ). IPA pathway analysis (a comparison across the canonical pathways), comparing the three C/EBPα deletion arrays with the acute PPARγ deletion array on chow diet ( Supplementary  Tables 1-4 ) showed that 3 days post C/EBPα deletion (on either chow or HFD) had no overlap with pathway changes 3 days post PPARγ deletion on chow diet. Interestingly, expression patterns 1 month post C/EBPα deletion shared 12 common pathways with 3 days of PPARγ deletion on chow diet ( Supplementary Fig. 7 ). We conclude that compared to the genes identified in Adn-C/EBPα −/− mice on the chow diet, most of the C/EBPα targets in mature adipocytes are genes modulated by long-term HFD feeding, and these targets share significant overlap with the changes observed after acute PPARγ loss on chow diet.
Fat expansion in ob/ob mice depends on C/EBPα
We next tested whether C/EBPα is essential for adipose tissue expansion in leptin-deficient mice. As soon as ob/ob Adn-C/EBPα flox/flox mice were started on the doxycycline treatment ( Fig. 5a ), these mice stopped gaining additional body weight (Fig. 5b) . WATs in the ob/ob Adn-C/EBPα −/− mice were much smaller ( Supplementary Fig. 8a) , and after 6 months sWAT and eWAT of ob/ob Adn-C/EBPα −/− mice are less than half of the WAT in their ob/ob control littermates (Fig. 5c) . Surprisingly, adipocytes in ob/ob Adn-C/EBPα −/− mice retained a similar morphology in sWAT, eWAT and BAT, and the average adipocyte size in sWAT and eWAT was not altered (Fig. 5d ). The average adipocyte numbers per image are: sWAT, ob/ob control group, 86; ob/ob Adn-C/EBPα −/− group, 82; eWAT, ob/ob control group, 59; ob/ob Adn-C/EBPα −/− group, 74. n = 2 images per group. Thus, the total number of adipocytes in ob/ob Adn-C/EBPα −/−(E11−P16) mice is 14% (sWAT) and 40% (eWAT) of their ob/ob control littermates. These remaining adipocytes in ob/ob Adn-C/EBPα −/− mice were 100% positive for perilipin staining (Fig. 5e) , indicating that the cells in these depots are live adipocytes, even after prolonged absence of C/EBPα. Liver weights of ob/ob Adn-C/EBPα −/− mice were not altered; thus, the ratio of liver weight to total body weight is markedly higher in the Adn-C/EBPα −/− mice (Fig. 5c) , with worse hepatic steatosis (Fig. 5f ). Similar to Adn-C/EBPα −/− mice, ob/ob Adn-C/EBPα −/− exhibited enhanced glucose intolerance ( Supplementary Fig. 8b ) and a higher rate of hepatic VLDL-triglyceride production ( Supplementary Fig. 8c ). ob/ob Adn-C/EBPα −/− mice also had significantly increased oxygen consumption ( Supplementary Fig. 8d ), associated with an increase in RER ( Supplementary Fig. 8e ), indicating that the mice are more prone to glucose utilization. ob/ob Adn-C/EBPα −/− mice also exhibited slightly increased activity during the night time ( Supplementary  Fig. 8f ). Combined, these observations indicate that deleting C/EBPα both in the context of an HFD and in the absence of leptin causes attenuation of adipose tissue expansion and a worsening of insulin resistance and dyslipidemia, represent a typical lipodystrophic model 38 .
Our previous study demonstrated that ob/ob mice with adiponectin overexpression (ob/ob AdTg mice) have significantly enlarged WAT (ref. 39) . Here, we crossed the ob/ob Adn-C/EBPα flox/flox mice with AdTg mice (Fig. 5a) . Surprisingly, these ob/ob Adn-C/EBPα flox/flox AdTg mice gained weight at the same rate as the ob/ob control littermates (Fig. 5g ). The circulating adiponectin levels dropped markedly in ob/ob Adn-C/EBPα −/− mice, and adiponectin levels were restored in the ob/ob Adn-C/EBPα −/− AdTg mice (Fig. 5h) . Glucose intolerance, on the other hand, was not restored by adiponectin overexpression (Fig. 5i ). WAT mass was preserved in the Adn-C/EBPα −/− AdTg mice (Fig. 5j) . These results indicate that by restoring adiponectin in circulation on C/EBPα deficiency, the associated attenuation of adipose tissue expansion in ob/ob mice can be overcome.
Adult white, but not beige, adipogenesis depends on C/EBPα
So far, our data have shown that C/EBPα is not required for embryonic white adipogenesis, but critical for adipose tissue expansion during HFD or in leptin-deficient mice. Here, we generated a more direct model to study the role of C/EBPα in adult adipogenesis in vivo, by crossing the inducible C/EBPα knockout system with our previously characterized FAT-ATTAC mice (fat apoptosis through triggered activation of caspase 8; ref. 40 ) to obtain FAT-ATTAC/Adn-C/EBPα flox/flox mice (Fig. 6a) . The FAT-ATTAC mice carry a transgene encoding a caspase 8 protein fused to a dimerization domain under the control of the aP2 adipocyte-specific promoter. The adipocytes in FAT-ATTAC/Adn-C/EBPα flox/flox mice were alive with positive perilipin staining before dimerization (Fig. 6b) . On a single treatment with dimerizer, apoptosis is initiated in every adipocyte. Seven days after dimerization, sWAT and eWAT sizes were markedly reduced ( Fig. 6c ) and adipocytes were uniformly dead, with disrupted morphology and negative perilipin signal (Fig. 6b ). By the fourth week post dimerization, both sWAT and eWAT recovered to around half of their original tissue mass in FAT-ATTAC/Adn-C/EBPα flox/flox mice kept on chow diet (Fig. 6d ). These mice exhibited ∼100% perilipinpositive adipocytes 6 week post dimerization ( Fig. 6b ), suggesting active de novo adipogenesis during the recovery stage. The FAT-ATTAC/Adn-C/EBPα −/− mice kept on doxycycline chow diet for 6 weeks post dimerization continued to exhibit a disrupted morphology, with predominantly negative perilipin staining in both sWAT and eWAT (Fig. 6b ). By week 4 of recovery post dimerization, FAT-ATTAC/Adn-C/EBPα −/− mice kept on doxycycline chow diet had smaller fat pads after dimerization, compared with FAT-ATTAC/Adn-C/EBPα flox/flox mice kept on chow diet (Fig. 6d) . These results indicate that new adipocytes cannot effectively form during the recovery stage without the presence of C/EBPα. Adipogenesis also occurs within skeletal muscle after injury. After glycerol-induced injury, fibrous tissue is generated around the injection area, and white adipocytes are gradually generated at the site of injury 41 . We tested whether C/EBPα is required for adipogenesis in muscle (Fig. 6e ). Three weeks post-injection, muscle from Adn-C/EBPα −/− mice showed only fibrous tissue but no adipocytes, while muscle from the control littermates showed visible adipocytes (Fig. 6f) . In control mice, mRNA of adipocyte markers, such as Adipsin and Adiponectin, were all markedly increased in the glycerol-injected side compared with the PBS-injected side (Fig. 6g ). Adipsin and adiponectin expression levels in the glycerol-injected side of Adn-C/EBPα −/− mice were comparable to the PBS-injected side of control mice, but far below the values for the glycerol-injected side of control mice (Fig. 6g ). This indicates that the muscle injury-induced adipogenesis in adult mice also critically depends on the presence of C/EBPα.
We have previously found that beige adipocytes induced by cold exposure arise from de novo adipogenesis 31 . We determined whether C/EBPα is essential for beiging of WAT (Fig. 7a) . Surprisingly, 10 days after cold exposure, expression levels of the beige adipocyte markers Ucp1 and Tmem26 in Adn-C/EBPα −/− mice were normal (Fig. 7b ). Both control and Adn-C/EBPα −/− mice showed massive browning morphology in sWAT (Fig. 7c) , with positive UCP1 staining (Fig. 7d ). This distinct absence of the requirement for C/EBPα in this process indicates that although C/EBPα is indispensable for white adipogenesis in adult mice, beige adipogenesis is a unique process that differs from white adipogenesis in the adult that does not require C/EBPα at all.
DISCUSSION
Our study reveals that white adipogenesis in adult mice utilizes distinct mechanisms during embryonic development or beige adipogenesis ( Fig. 8 ). One of our most important results presented here is that the precursor cells giving rise to adipocytes during embryogenesis are different from the precursor cells giving rise to adipocytes in the mature animal, at least as far as the requirements for C/EBPα are concerned. We have tested the requirements of C/EBPα under a number of different adipogenic occasions in adult mice, and the results were quite clear: adipocyte maturation cannot happen while deleting C/EBPα during late white adipogenesis in adult mice under many conditions. In the FAT-ATTAC model, the transgene encoding the caspase 8 fusion protein of FAT-ATTAC mice is under the control of the aP2 promoter, which has been shown to be active in other cell types. The lack of specificity of this aP2 promoter cassette may cause irreversible changes in whole-body metabolism. However, our initial characterization of the FAT-ATTAC transgene neither revealed significant expression, nor was it found to cause apoptosis, in any of these other cell types. As WAT effectively regenerates post dimerization, we believe that adipocyte precursors are not affected or eliminated by the transgene.
Beige adipogenesis occurs within sWAT after cold exposure, and arises from de novo adipogenesis and is believed to originate from unique precursor cells 42, 43 . We have previously shown that rtTA is expressed in the beige cells in AdipoChaser mice 31 . In this study, we found that deleting C/EBPα during beige adipogenesis has no impact on the formation and function of beige adipocytes. These results indicate that C/EBPα expression in the maturation stage is essential only for white adipogenesis in the adult, not for beige adipogenesis or embryonic adipogenesis. We appreciate that sWAT and eWAT have distinct morphology and functions, and these two fat depots may have unique precursor pools, responding to differential developmental and nutritional cues [44] [45] [46] [47] [48] . Here, we show a differential temporal requirement for C/EBPα for adipogenesis within the same fat depot.
We have also tested the loss of function of PPARγ under all adult adipogenesis conditions that we have examined for C/EBPα, using the Adn-PPARγ flox/flox model. In general, PPARγ is required in the adult mouse under all conditions that require adipogenesis. However, in contrast to C/EBPα, PPARγ is also required for the survival of mature adipocytes. On inducible PPARγ deletion, the overall structure and viability of the fat pad is negatively affected, which is consistent with a recent publication 33 . It is difficult to assess de novo adipogenesis under these conditions.
Adiponectin is known to be regulated by C/EBPα (refs 49-51) . In our inducible knockout system, adiponectin levels were reduced markedly after as little as two days of C/EBPα deletion, that is, one of the earliest read-outs of C/EBPα deficiency. The systemic loss of adiponectin also argues that we systematically eliminate C/EBPα in all fat pads. We were surprised that adiponectin overexpression in the ob/ob background can rescue the attenuation of WAT expansion due to C/EBPα deficiency. Although adiponectin is not required for WAT formation in vitro or in vivo 52 , it is unknown how adiponectin is involved in WAT expansion and regeneration in adult mice, especially when mice are facing metabolic challenges. Our previous results indicated that adiponectin is highly correlated with healthy expansion of WAT, as well as whole-body lipid and glucose metabolism 39, [53] [54] [55] [56] [57] .
Here, we show that a simple increase of adiponectin can restore adipogenesis in adult mice in the absence of C/EBPα, indicating yet again that the process of adipogenesis shares different mechanisms at different stages of an individual's life. This result also highlights that adiponectin not only controls adipocyte function, it may also directly control adipogenesis under certain conditions.
In vitro studies have shown that most genes induced in adipogenesis are targets for both PPARγ and C/EBPα (refs 13,14) . However, here we demonstrate that PPARγ and C/EBPα control distinct transcriptional programs with very limited overlap in vivo. This observation indicates that C/EBPα is distinct from PPARγ in regulating the function of mature adipocytes, at the level of direct targets under healthy conditions. Not surprisingly, there is a notable lack of phenotypic changes in C/EBPα-deficient mice kept on a chow diet. When kept on HFD for 1 month, the C/EBPα-specific transcriptional programs are visible at a much broader range in sWAT, and these programs begin to overlap with acute PPARγ-specific transcriptional programs, suggesting that C/EBPα is regulating mostly pathways modulated by high dietary fat exposure. This in turn is consistent with the fact that C/EBPα elimination in the WAT of mice kept on HFD resulted in rapid dysfunction of glucose and lipid metabolism.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper DOI: 10.1038/ncb3217
M E T H O D S
inhibit triglyceride clearance during VLDL secretion experiments. Serum samples were taken from the tail vein every hour for triglyceride analysis. For lipoprotein fractionation analysis, equal volumes of serum samples were pooled (for a total of 0.4 ml) from 6 mice per group. The pooled plasma from each group was subjected to FPLC gel filtration on a Superose 6 10/300 GL FPLC column (Amersham Biosciences). The fractions (0.5 ml) were collected and total triglycerides and cholesterol levels of each fraction were determined using the Infinity Triglyceride and Cholesterol Kit (Thermo Electron Corporation).
Mouse muscle injury and recovery. Fifty microlitres of 50% v/v glycerol was intramuscularly injected into the tibialis anterior muscle of the right leg, while 50 µl of PBS was injected into the left leg 61 . The injection was performed under anaesthesia using isoflurane inhalation. Mice were euthanized 3 weeks after injection and the tibialis anterior muscles were collected for histology or RNA extraction.
Reproducibility of experiments.
For the requirement of C/EBPα or PPARγ during terminal embryonic adipogenesis (Fig. 1) , there were two independent experiments. For C/EBPα deletion in differentiated SVF (Fig. 2) , there were three independent experiments. For adiponectin level in the circulation (Fig. 3d ), there were three independent experiments. For Adn-C/EBPα flox/flox mice fed on a dox high fat diet (Fig. 4b) , there were three independent experiments. For GTT on Adn-C/EBPα flox/flox mice fed on a dox high fat diet (Fig. 4g,h) , there were two independent experiments. For ob/ob Adn-C/EBPα flox/flox mice fed on a dox chow diet (Fig. 5b,c) , there were two independent experiments. For ob/ob Adn-C/EBPα flox/flox AdTg mice fed on a dox chow diet, there were two independent experiments. For muscle injury in Adn-C/EBPα flox/flox mice (Fig. 6g ), there were two independent experiments. For cold-induced beige adipogenesis in Adn-C/EBPα flox/flox mice (Fig. 6g ), there were two independent experiments. For tissue profile of C/EBPa knockdown ( Supplementary Fig. 1b ), there were two independent experiments. For fat floating ( Supplementary Fig. 1c ), there were two independent experiments. For triglyceride content of the VLDL fractions and cholesterol content of the highdensity lipoprotein fractions ( Supplementary Fig. 5a,b ), there were two independent experiments. For the rest of results shown in the figures, there was no replication of mouse experiments. There is no estimate of variation in each group of data and the variance is similar between the groups. No statistical method was used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. All data are expected to have normal distribution.
Statistical analysis. Data are presented as means ± s.e.m. Differences were analysed by unpaired two-tailed t-test between two groups or otherwise by two-way ANOVA. 
